8F0F

HIV-1 wild type protease with GRL-110-19A, a chloroacetamide derivative based on Darunavir as P2' group

Summary for 8F0F

Entry DOI	10.2210/pdb8f0f/pdb
Related	2IEN 6U7O
Descriptor	Protease, SODIUM ION, CHLORIDE ION, ... (6 entities in total)
Functional Keywords	aspartic acid protease, hiv-1 protease, darunavir, a chloroacetamide derivative inhibitor, antiviral protein, hydrolase-inhibitor complex, hydrolase/inhibitor
Biological source	Human immunodeficiency virus 1
Total number of polymer chains	2
Total formula weight	22326.94
Authors	Wang, Y.-F.,Agniswamy, J.,Ghosh, A.K.,Weber, I.T. (deposition date: 2022-11-02, release date: 2023-02-15, Last modification date: 2023-10-25)
Primary citation	Ghosh, A.K.,Shahabi, D.,Kipfmiller, M.,Ghosh, A.K.,Johnson, M.,Wang, Y.F.,Agniswamy, J.,Amano, M.,Weber, I.T.,Mitsuya, H. Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studies. Bioorg.Med.Chem.Lett., 83:129168-129168, 2023 Cited by PubMed: 36738797 DOI: 10.1016/j.bmcl.2023.129168 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.29 Å)

Structure validation